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Although Lactobacilli are generally considered probiotic agents in metazoans, the underlying molecular
mechanisms are largely unknown. In this issue of Cell Host & Microbe, Erkosar et al. (2015) reveal that a
Drosophila gut commensal, Lactobacillus plantarumWJL, promotes animal growth by enhancing the host’s
capacity for protein degradation.Sophisticated physiology, such as devel-
opmental timing and the speed of an
animal, is classically viewed as a self-
governing process assisted by the ani-
mal’s genomic information. However,
microorganisms were established on
Earth long before the emergence of ani-
mals. Therefore, regulatory mechanisms
governing animal physiology would have
been established and evolved under the
strong influences of animal-associated
microorganisms. In the early 20th century,
it was observed that germ-free (GF) flies
devoid of their gut microbiota, such as
the GF blowfly (Calliphora vomitoria)
showed reduced developmental rates
and often developmental defects, result-
ing in a smaller body size (for review, see
Lee and Brey, 2013). These observations
supported the concept of probiotics pro-
posed by E´lie Metchnikoff, wherein he
attributed a beneficial role of some bacte-
ria in animal health. Specifically, he
speculated that Lactobacilli, particularly
L. bulgaricus, were very helpful in human
health, possibly by competing with
toxin-producing flora via lactic acid pro-
duction (Lee and Brey, 2013). Although
the probiotic concept associated with
Lactobacilli was introduced over a cen-
tury ago, the use of these bacteria in
human health via the consumption of
fermented dairy food may be traced
back to more than 10,000 years ago,
when humans began to domesticate dairy
animals. However, despite a long histori-
cal use of probiotics, detailed molecular
mechanisms underlying host-Lactobacilli
interactions remain obscure.
Members of the genus Lactobacillus
are found in very diverse ecological
niches, such as mucosal surfaces of388 Cell Host & Microbe 18, October 14, 201different animals, including the human
gut. Strain-specific probiotic effects of
different species of Lactobacillus are
extensively studied (Oelschlaeger, 2010),
but we still have a limited understanding
of the detailed mechanisms by which
Lactobacilli impact animal physiology.
Recently, Drosophila has emerged as
an important model because different
members of the Acetobacteraceae and
Lactobacillaceae family are two dominant
natural commensal gut bacteria in
Drosophila (Ryu et al., 2008; Shin et al.,
2011; Storelli et al., 2011). Therefore,
naturally occurring animal-Lactobacillus
interactions can be dissected by taking
advantage of powerful genetic tools avail-
able in Drosophila. Some unexpected
roles of Lactobacilli have been elucidated
in this model organism. For example,
it has been shown that a strain of
L. plantarum can affect the mating
behavior of adult Drosophila (Sharon
et al., 2010). Previously, Leulier and col-
leagues showed that L. plantarumWJL
strain, originally isolated from laboratory
Drosophila gut (Ryu et al., 2008), en-
hances larval development under condi-
tions of poor nutrition by inducing insulin
and ecdysone signaling possibly via
TOR activation (Storelli et al., 2011) (see
steps 5–9 in Figure 1). TOR activity is
known to be mainly activated by diet-
derived branched-chain amino acids.
Consistent with this, inactivation of slim-
fast, a gene encoding a transporter
necessary for the intracellular uptake of
circulating amino acids, is sufficient
to abolish Lactobacillus-induced animal
growth (Storelli et al., 2011). Based on
these observations, it has been sug-
gested that L. plantarum may exert its5 ª2015 Elsevier Inc.growth-promoting effects by maintaining
optimal amino acid levels necessary for
appropriate TOR activity. However, the
exact molecular mechanism by which
L. plantarumWJL supports host growth re-
mains to be elucidated.
In this issue, Erkosar et al. (2015) show
that Lactobacilli association maintains
proper peptidase expression levels of en-
terocytes. This is mediated partly by Lac-
tobacilli-mediated induction of NF-kB
signaling, which is required for increased
intestinal proteolytic enzyme activity
(therefore enhanced food-derived pro-
tein digestion), resulting in higher amino
acid levels in host animals. Importantly,
they further show that Lactobacillus-
mediated benefits can be antagonized
upon foodborne pathogen infection, high-
lighting a complex interplay between
commensal-induced development and
pathogen-induced immunity. Previously,
by comparative transcriptome analyses
between GF flies and conventionalized
GF flies (GF flies re-associated with
commensal community members), they
observed that several peptidase genes
are significantly upregulated in the pres-
ence of gut commensal bacteria (Erkosar
et al., 2014). As they initially speculated
that L. plantarum induces TOR-depen-
dent host growth promotion by enhancing
amino acid assimilation (Storelli et al.,
2011), this observation prompted them
to investigate whether the presence of
Lactobacillus alone would be sufficient
to induce the expression of these
digestive enzymes. Time course quanti-
tative analyses of gene expression re-
vealed that Lactobacillus association
was sufficient to trigger an overall
increase in the expression levels of
Figure 1. Model for Lactobacillus-Induced Growth-Promoting Signaling Pathways and Their
Relationships with Pathogen-Induced Immune Signaling Pathways
(1) Commensal bacteria release peptidoglycan, which moderately activates the IMD pathway, leading to
Relish activation and expression of Relish-dependent target genes, such as peptidase genes. (2) It
should be noted that peptidase genes are, in addition to the IMD pathway, regulated by an unidentified
signaling pathway that functions in a Lactobacillus strain-specific manner. (3) Peptidases enhance the
degradation of diet-derived proteins under conditions of poor nutrition, resulting in a high level of amino
acids (AA) and dipeptides. (4) Absorption of these amino acids and dipeptides. (5) Branched-chain
amino acids are transported by slimfast in the fat body and prothoracic gland, which leads to TOR
activity in these organs. (6) Fat body TOR activity somehow stimulates insulin-producing cells.
(7) Release of insulin-like peptides from insulin-producing cells. (8) TOR activity in the prothoracic gland
induces ecdysone release. (9) Insulin-like peptides and Ecdysone stimulate larval growth. (10) Upon
pathogen infection, large amounts of PG molecules highly activate the IMD pathway to turn on distinct
innate immune effector genes such as antimicrobial peptide genes. (11) In this condition, pathogens
also activate a presently unidentified ‘‘evf-specific signaling pathway’’ that antagonizes a ‘‘Lactobacillus
strain-specific signaling pathway,’’ thereby acting as a physiological switch. In this issue, Erkosar et al.
(2015) discover multiple steps (1–4 and 11) of this model. PG, peptidoglycan; evf, erwinia virulence
factor; TOR, target of rapamycin; IMD, immune deficiency; PGRPs, peptidoglycan recognition proteins;
Rel, Relish.
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Jon66Cii, Jon66Ci, Jon44E, Jon65Ai,
Jon99Ci, CG18179, and CG18180).
Consistent with enhanced peptidase
expression, Lactobacillus association
induced an increase in proteolytic
enzyme activity when introduced into
the gut of GF animals. When animals
were fed a diet containing protease inhib-
itors, the growth-promoting effects of
L. plantarumWJL were diminished, indi-
cating that Lactobacillus-induced intesti-
nal peptidase activity is required for hostgrowth. Importantly, the ectopic overex-
pression of a single Jon66Cii peptidase
in enterocytes of a GF animal was suffi-
cient to promote larval growth and was
comparable to that seen in the Lactoba-
cillus-associated GF animal, indicating
that Lactobacillus-induced peptidase
activity is necessary and sufficient for
Drosophila larval growth under poor nutri-
tional conditions. To further confirm
whether enhanced peptidase expression
increases protein digestion capacity lead-
ing to high amino acid levels, the authorsCell Host & Microbe 18analyzed 21 amino acids and 50 dipep-
tides in a quantitative manner. Most free
amino acids, including essential amino
acids as well as dipeptides, increased in
Lactobacillus-associated animals, indi-
cating that Lactobacillus association
indeed leads to higher protein digestion
capacity, resulting in higher amino acid
levels.
How does Lactobacillus association
induce the expression of peptidase
genes? In Drosophila, two NF-kB path-
ways, referred to as the Toll and immune
deficiency (IMD) pathways, have been
discovered so far (Lemaitre and Hoff-
mann, 2007). It has been previously
shown that only the IMD pathway oper-
ates in the gut epithelium. In the IMD
pathway, peptidoglycan (PG, a bacterial
cell wall component) molecules released
from bacteria are recognized by peptido-
glycan receptors located in the enterocyte
membrane, which in turn initiates an intra-
cellular signaling pathway leading to the
activation of Relish, aDrosophila homolog
of mammalian p105-like NF-kB. The
active form of Relish subsequently in-
duces the expression of many important
genes involved in innate immunity. It
has recently been shown that the IMD
pathway also plays a central role in
the expression of microbiota-modulated
host genes, including intestinal digestive
enzymes (Erkosar et al., 2014). However,
Erkosar et al. (2015) found that not all
peptidase expression is influenced by
the IMD pathway; some peptidases are
partly IMD dependent, while others are
also IMD independent. Consistent with
this observation, they observed that loss
of function of the IMD pathway is not suf-
ficient to abolish Lactobacillus-induced
peptidase activity and Lactobacillus-
induced growth promotion. All of these
data suggest that each peptidase has a
different degree of IMD dependency,
and Lactobacillus-induced signaling
pathway(s) other than IMD are also
involved in the regulation of different
peptidases (see step 2 in Figure 1). Impor-
tantly, the authors found that Lactoba-
cillus-mediated peptidase induction can
be abolished upon foodborne infection
with a well-known enteric pathogen,
Erwinia carotovora carotovora 15 (Ecc15)
strain. During this enteric infection, strong
activation of the IMD pathway occurs (see
step 10 in Figure 1), while induction of all
seven peptidase genes, even that of, October 14, 2015 ª2015 Elsevier Inc. 389
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IMD dependent, is severely impaired.
Accordingly, Lactobacillus-induced intes-
tinal proteolytic activity was almost
completely abolished following enteric
infection, thereby antagonizing the
Lactobacillus-induced growth-promoting
effect. Although enteric infection antago-
nizes Lactobacillus-induced growth pro-
motion, it does not alter the growth of
GF animals. These data indicate that
enteric infection specifically antagonizes
Lactobacillus-induced signaling path-
ways (see step 2 and 11 in Figure 1). As
gut-specific overexpression of a single
Jon66Cii peptidase is sufficient to sup-
press the growth-antagonizing effect
of Ecc15, the authors concluded that
Ecc15 pathogen infection inhibits Lacto-
bacillus-mediated growth promotion by
negatively regulating the expression of in-
testinal peptidase genes.
As this antagonizing effect can also be
observed in an IMD pathway mutant an-
imal, IMD pathway activation is dispens-
able for infection-induced antagonism.
However, when they performed an infec-
tion with avirulent Ecc15 strain lacking
the erwinia virulence factor (evf) gene
(Basset et al., 2003), the authors found
that Lactobacillus-induced growth pro-
motion was not affected. Therefore,390 Cell Host & Microbe 18, October 14, 201enteric infection may induce a signaling
pathway in an evf-specific manner that
in turn antagonizes strain-specific Lacto-
bacillus signaling (see step 2 and 11
in Figure 1). This growth-antagonizing
effect of Ecc15 would act as a physio-
logical switch shifting the expression
of digestive genes involved in meta-
bolism and development to the expres-
sion of innate immune effector genes
involved in pathogen resistance and tis-
sue repair.
These discoveries raise several inter-
esting questions for future research
directions. What is the Lactobacillus-
induced signaling pathway involved in
the induction of peptidase expression?
How does this signaling pathway operate
in a Lactobacillus strain-specific manner?
What is the Ecc15-induced signaling
pathway capable of antagonizing Lacto-
bacillus-induced host growth? What is
the molecular mechanism by which
the evf-specific signaling inhibits the
Lactobacillus strain-specific signaling
pathway? What is the in vivo value of
this physiological switch? Further investi-
gations will provide mechanistic insights
into the probiotic functions of Lactobacilli
in Drosophila and, hopefully, in more
complex mammalian organisms, includ-
ing humans.5 ª2015 Elsevier Inc.ACKNOWLEDGMENTS
The authors are supported by a grant (No.
2015R1A3A2033475) from National Research
Foundation of Korea. We thank Dr. Kyung-Ah Lee
for the artworks.
REFERENCES
Basset, A., Tzou, P., Lemaitre, B., and Boccard, F.
(2003). EMBO Rep. 4, 205–209.
Erkosar, B., Defaye, A., Bozonnet, N., Puthier, D.,
Royet, J., and Leulier, F. (2014). PLoS ONE 9,
e94729.
Erkosar, B., Storelli, G., Mitchell, M., Bozonnet, L.,
Bozonnet, N., and Leulier, F. (2015). Cell Host
Microbe 18, this issue, 445–455.
Lee, W.-J., and Brey, P.T. (2013). Annu. Rev. Cell
Dev. Biol. 29, 571–592.
Lemaitre, B., and Hoffmann, J. (2007). Annu. Rev.
Immunol. 25, 697–743.
Oelschlaeger, T.A. (2010). Int. J. Med. Microbiol.
300, 57–62.
Ryu, J.-H., Kim, S.-H., Lee, H.-Y., Bai, J.Y., Nam,
Y.-D., Bae, J.-W., Lee, D.G., Shin, S.C., Ha, E.-M.,
and Lee, W.-J. (2008). Science 319, 777–782.
Sharon, G., Segal, D., Ringo, J.M., Hefetz, A.,
Zilber-Rosenberg, I., and Rosenberg, E. (2010).
Proc. Natl. Acad. Sci. USA 107, 20051–20056.
Shin, S.C., Kim, S.-H., You, H., Kim, B., Kim, A.C.,
Lee, K.-A., Yoon, J.-H., Ryu, J.-H., and Lee, W.-J.
(2011). Science 334, 670–674.
Storelli, G., Defaye, A., Erkosar, B., Hols, P., Royet,
J., and Leulier, F. (2011). Cell Metab. 14, 403–414.Streptococcal M1 Strikes by Neutralizing CathelicidinsBirgitta Henriques-Normark1,2,* and Staffan Normark1,2
1Department of Microbiology, Cell Biology and Tumorbiology, Karolinska Institutet, 171 77 Stockholm, Sweden
2Department of Clinical Microbiology, Karolinska University Hospital, 171 76 Stockholm, Sweden
*Correspondence: birgitta.henriques@ki.se
http://dx.doi.org/10.1016/j.chom.2015.10.002
Virulent group A streptococci have become a serious threat, with the emergence of the hypervirulent lineage
M1T1. In this issue of Cell Host & Microbe, LaRock et al. (2015), uncover a role for the streptococcal M1 pro-
tein in neutralizing a key human antimicrobial peptide, cathelicidin.Since the mid-1980s, group A strepto-
cocci (GAS) have reemerged as a cause
of severe invasive infections, such as sep-
tic shock, puerperal sepsis, soft-tissue in-
fections including necrotizing fasciitis,
and streptococcal toxic shock syndrome.
Despite increased awareness and bettertreatment of the most severe disease
manifestations, the mortality rate remains
high, often exceeding 50%. To date, more
than 150 different M protein sequence
types (emm types) have been described
for GAS. Although the most severe forms
of invasive GAS infections, streptococcaltoxic shock syndrome and necrotizing
fasciitis, can be caused by a large number
of emm types, they are particularly asso-
ciated with emm1 (M1). One example
of the rapid progress of M1 infections
was recently reported for three cases
of fulminant hemorrhagic pneumonia in
